Sažetak sa skupa
https://doi.org/10.26800/LV-144-supl6-PS22
Relapse of an atypical hemolytic-uremic syndrome triggered by COVID-19
Mihaela Benčić
Marina Andrešić
Maša Sorić
Sažetak
Atypical hemolytic-uremic syndrome (aHUS) is a rare thrombotic microangiopathy (TMA) characterized by genetic or acquired deregulation of alternative complement pathway with the clinical triad of microangiopathic hemolytic anemia, thrombocytopenia, and acute kidney injury (AKI). Within precipitating biological factors, several pathogens were identified. To date, only a few cases of aHUS relapses triggered by COVID-19 have been reported.
Ključne riječi
COVID-19; hemolytic-uremic syndrome, atypical; thrombotic microangiopathy
Hrčak ID:
291085
URI
Datum izdavanja:
8.12.2022.
Posjeta: 922 *